Precipio Inc Quick Ratio (PRPO) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Precipio inc   (NASDAQ: PRPO)

Precipio Inc 's Quick Ratio

PRPO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Precipio Inc 's Cash & cash equivalent grew by 16.29 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Precipio Inc 's Quick Ratio to 0.9, Quick Ratio remained below Precipio inc average.

Within Laboratory Analytical Instruments industry 13 other companies have achieved higher Quick Ratio than Precipio Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 1677 to 1971.

Explain Quick Ratio?
How much Cash & cash equivalents PRPO´s has?
What are PRPO´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PRPO/financial-strength
https://api.csimarket.com/api/v1/companies/PRPO/fundamentals
https://api.csimarket.com/api/v1/companies/PRPO/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
PRPO Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 10.82 %
Y / Y Cash & cash equivalent Change 55.14 %
Quick Ratio MRQ 0.9
PRPO's Total Ranking # 1971
Seq. Current Liabilities Change 7.67 %
Seq. Cash & cash equivalent Change 16.29 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 14
Healthcare Sector # 660
Overall Market # 1971


Quick Ratio Statistics
High Average Low
16.51 1.05 0
(Jun 30 2019)   (Mar 31 2017)




Financial Statements
Precipio Inc 's Current Liabilities $ 4 Millions Visit PRPO's Balance sheet
Precipio Inc 's Cash & cash equivalent $ 4 Millions Visit PRPO's Balance sheet
Source of PRPO's Sales Visit PRPO's Sales by Geography


Cumulative Precipio Inc 's Quick Ratio

PRPO's Quick Ratio for the trailling 12 Months

PRPO Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -7.49 %
Y / Y Cash & cash equivalent TTM Growth 103.83 %
Quick Ratio TTM 0.88
Total Ranking TTM # 4047
Seq. Current Liabilities TTM Growth 2.95 %
Seq. Cash & cash equivalent TTM Growth 11.95 %


On the trailing twelve months basis PRPO Cash & cash equivalent soared by 55.14 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Precipio Inc 's Quick Ratio to 0.88, Quick Ratio remained below PRPO average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 22 other companies have achieved higher Quick Ratio than Precipio Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2862 to 4047.

Explain Quick Ratio?
How much Cash & cash equivalents PRPO´s has?
What are PRPO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 23
Healthcare Sector # 901
Within the Market # 4047


trailing twelve months Quick Ratio Statistics
High Average Low
6.78 1.07 0.01
(Sep 30 2019)   (Mar 31 2017)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Laboratory Analytical Instruments Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Quanterix Corporation  1.51 $ 77.359  Millions$ 51.130  Millions
Nautilus Biotechnology Inc   1.07 $ 10.467  Millions$ 9.758  Millions
Precipio inc   0.90 $ 3.576  Millions$ 3.985  Millions
Bio rad Laboratories Inc   0.86 $ 837.100  Millions$ 969.100  Millions
Bionano Genomics Inc   0.66 $ 8.168  Millions$ 12.307  Millions
Revvity Inc  0.63 $ 592.799  Millions$ 936.977  Millions
Avantor Inc   0.34 $ 464.300  Millions$ 1,369.000  Millions
Waters Corporation  0.27 $ 593.000  Millions$ 2,180.000  Millions
Harvard Bioscience Inc   0.19 $ 4.856  Millions$ 26.127  Millions

Date modified: 2026-11-11T13:57:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.